Neuromuscular blocking agents

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/69

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:09 PM on 6/27/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

70 Terms

1
New cards

What are muscle relaxants?

Drugs that affect muscle tone

2
New cards

What are the two major groups of muscle relaxants?

Neuromuscular blockers and spasmolytics

3
New cards

How do neuromuscular blockers act?

Interfere with transmission at neuromuscular end plate causing paralysis without CNS activity

4
New cards

What are neuromuscular blockers used for?

Adjuncts to general anesthesia

5
New cards

How do spasmolytics act?

Centrally and peripherally to reduce tone without loss of voluntary power

6
New cards

What are spasmolytics used for?

Chronic spastic conditions, acute spasms, tetanus, musculoskeletal pain

7
New cards

What is curare?

Mixture of alkaloids like tubocurarine used historically as poison and muscle relaxant

8
New cards

What is the site of action of neuromuscular blockers?

Neuromuscular junction of skeletal muscle fibers

9
New cards

What receptor is targeted by neuromuscular blockers?

Nicotinic NM cholinergic receptor

10
New cards

Neuromuscular blockers are analogues of which neurotransmitter?

Acetylcholine

11
New cards

What are the two classes of neuromuscular blockers?

Non‑depolarizing (competitive antagonists) and depolarizing (agonists)

12
New cards

Examples of non‑depolarizing blockers?

Tubocurarine, Pancuronium, Vecuronium, Rocuronium

13
New cards

Example of depolarizing blocker?

Succinylcholine (suxamethonium)

14
New cards

MOA of non‑depolarizing blockers?

Bind NM receptor, prevent ACh binding, block Na+ channel opening → flaccid paralysis

15
New cards

How can non‑depolarizing blockade be reversed?

By anticholinesterase drugs like neostigmine or ↑ACh concentration

16
New cards

Do non‑depolarizing blockers affect consciousness or pain?

No, only paralysis

17
New cards

Order of paralysis with non‑depolarizing blockers?

Eye muscles → facial muscles → limbs/pharynx → respiratory muscles

18
New cards

Onset and duration of tubocurarine?

Slow onset >5 min, long duration 1–2 hrs

19
New cards

ADRs of tubocurarine?

Hypotension, histamine release, bronchospasm

20
New cards

Onset and duration of pancuronium?

Intermediate onset 2–3 min, long duration

21
New cards

ADRs of pancuronium?

Tachycardia, less hypotension

22
New cards

Onset and duration of vecuronium?

Intermediate onset, intermediate duration 30–40 min

23
New cards

ADRs of vecuronium?

Minimal

24
New cards

Onset and duration of rocuronium?

Fast onset ~2 min, intermediate duration 30–40 min

25
New cards

ADRs of rocuronium?

Minimal

26
New cards

MOA of depolarizing blockers?

Bind NM receptor, open Na+ channels, cause depolarization → fasciculations then flaccid paralysis

27
New cards

Why does succinylcholine cause prolonged depolarization?

Not metabolized by AChE, dissociates slowly, keeps Na+ channels inactivated

28
New cards

Phases of succinylcholine action?

Phase I fasciculations, Phase II flaccid paralysis

29
New cards

How is succinylcholine metabolized?

By plasma pseudocholinesterase (butyrylcholinesterase)

30
New cards

Duration of succinylcholine action?

Short 5–8 min

31
New cards

Can anticholinesterases reverse succinylcholine?

No, they prolong its effect

32
New cards

Clinical uses of succinylcholine?

Intubation, laryngoscopy, bronchoscopy, laryngospasm, short orthopedic manipulations, adjunct to ECT

33
New cards

Clinical uses of non‑depolarizing blockers?

Prolonged surgery, muscle relaxation, assisted ventilation

34
New cards

ADR of succinylcholine: bradycardia mechanism?

Direct muscarinic receptor action on heart

35
New cards

How to prevent succinylcholine‑induced bradycardia?

Atropine

36
New cards

Why does succinylcholine cause postoperative pain?

Due to fasciculations correlating with pain severity

37
New cards

Why does succinylcholine cause hyperkalemia?

K+ release from damaged cells especially burns or trauma

38
New cards

Consequence of succinylcholine‑induced hyperkalemia?

Cardiac arrhythmias

39
New cards

Why does succinylcholine cause prolonged apnea?

Genetic deficiency or atypical pseudocholinesterase

40
New cards

What is malignant hyperthermia?

Rare autosomal dominant disorder triggered by succinylcholine + inhaled anesthetics

41
New cards

Pathophysiology of malignant hyperthermia?

Abnormal RyR → excessive Ca2+ release from SR → muscle contraction + heat

42
New cards

Symptoms of malignant hyperthermia?

Hyperthermia >40°C, tachycardia, tachypnea, acidosis, rigid muscles, rhabdomyolysis

43
New cards

Lab findings in malignant hyperthermia?

↑ CK, hyperkalemia

44
New cards

Treatment of malignant hyperthermia?

Dantrolene

45
New cards

Which drug shortens tubocurarine action?

Neostigmine

46
New cards

Which drug potentiates succinylcholine malignant hyperthermia risk?

Halothane

47
New cards

Which agents reduce effect of non‑depolarizing blockers?

Cholinesterase inhibitors like neostigmine

48
New cards

Which agents potentiate non‑depolarizing blockers?

Halothane, aminoglycosides, calcium channel blockers, benzodiazepines

49
New cards

Which agents potentiate depolarizing blockers?

Inhaled anesthetics like halothane

50
New cards

MOA of diazepam as spasmolytic?

Binds GABAA receptor, enhances GABA transmission → muscle relaxation without paralysis

51
New cards

Clinical uses of diazepam?

Spastic neurological diseases, tetanus, epilepsy, ECT, orthopedic manipulations, anxiety

52
New cards

What is baclofen?

GABA analogue activating GABAB receptors in spinal cord → depresses reflexes

53
New cards

Clinical use of baclofen?

Spasticity in MS or spinal cord lesions

54
New cards

What is tizanidine?

Central α2 agonist inhibiting excitatory amino acid release in spinal interneurons

55
New cards

Clinical uses of tizanidine?

Spastic neurological diseases, temporomandibular joint disorder

56
New cards

MOA of dantrolene?

Acts peripherally on RyR Ca2+ channels in SR, prevents Ca2+ release → muscle relaxation

57
New cards

Clinical uses of dantrolene?

Spastic syndromes, malignant hyperthermia, neuroleptic malignant syndrome

58
New cards

ADRs of dantrolene?

Severe muscle weakness, hepatotoxicity, sedation, respiratory depression, blurred vision

59
New cards

What are botulinum toxins?

Toxins from Clostridium botulinum (Botox, Dysport, Myobloc)

60
New cards

MOA of botulinum toxins?

Block ACh release → flaccid paralysis

61
New cards

Duration of botulinum toxin effect?

3–4 months

62
New cards

Route of administration of botulinum toxins?

Local IM or intradermal injection

63
New cards

ADRs of botulinum toxins?

Respiratory paralysis from spread, anaphylaxis

64
New cards

Clinical uses of botulinum toxins?

Strabismus, blepharospasm, cerebral palsy spasticity, stroke spasticity, hyperhidrosis, sialorrhea, cosmetic wrinkles

65
New cards

Difference in site of action between depolarizing and non‑depolarizing blockers?

Both act at NMJ

66
New cards

Difference in receptor target between depolarizing and non‑depolarizing blockers?

Both target NM cholinergic receptor

67
New cards

Difference in effect on ACh between depolarizing and non‑depolarizing blockers?

Non‑depolarizing are antagonists, depolarizing are agonists

68
New cards

Difference in Na+ channel action between depolarizing and non‑depolarizing blockers?

Non‑depolarizing prevent opening, depolarizing open channels

69
New cards

Difference in muscle AP between depolarizing and non‑depolarizing blockers?

Non‑depolarizing block depolarization, depolarizing cause depolarization

70
New cards

Difference in paralysis pattern between depolarizing and non‑depolarizing blockers?

Non‑depolarizing cause flaccid paralysis, depolarizing cause fasciculations then flaccid paralysis